Mechanism of protection by diethyldithiocarbamate against cisplatin ototoxicity: Antioxidant system

Toxicological Sciences

Volumn 26, Issue 2, 1995, Pages 293-300

  Rybak, Leonard P ^a   Ravi, Radhika ^a   Somani, Satu M ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CISPLATIN; DIETHYLDITHIOCARBAMIC ACID; GLUTATHIONE; PROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDITORY THRESHOLD; COCHLEA; CONTROLLED STUDY; EVOKED BRAIN STEM AUDITORY RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; OTOTOXICITY; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALIA; RATTUS NORVEGICUS;

EID: 77957179384     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/26.2.293     Document Type: Article

References (60)

1. Aebi, N. (1984). Catalase in vitro. Methods Enzymol., 105, 121-126.
2. Anderson, M. E., Naganuma, A., and Meister, A. (1990) Protection against cisplatin toxicity by administration of glutathione ester. FASEB J., 4(14), 3251-3255.
3. Awasthi, Y. C., Singh, S. V., Ahmad, H., Wronski, L. W., Srivaslhava, S. K., and LaBelle, E. F. (1989). ATP dependent primary active transport of xenobiotic-glutathione conjugates by human erythrocyte membrane. Mol. Cell. Biochem., 91(1-2), 131-136.
4. Berry, J. M., Jacobs, C., Sikic, B., Halsey, J., and Borch, R. F. (1990). Modification of cisplatin toxicity with diethyldithiocarbamate. J. Clin. Oncol., 8, 1585-1590.
5. Borch, R. F., Katz, J. C., Lieder, P. N., and Pleasants, M. E. (1980). Effect of diethyldithiocarbamate rescue on tumor response to platinum in a rat model. Proc. Natl. Acad. Sci. USA 77(9), 5441-5444.
6. Borch, R. F., and Montine, T. J. (1990). Renal toxicity of antineoplastic agents. Toxicol. Lett., 53, 93-96.
7. Bradford, M. (1976). A rapid and sensitive method for the quantitation in microgram quantities of protein utilizing the principles of protein-dye binding. Anal. Biochem., 72, 248-254.
8. Brown, R. D., and Feldman, A. M. (1978). Pharmacology of hearing and ototoxicity. Annu. Rev. Pharmacol. Toxicol., 18, 233-252.
9. Capel, I. D. (1983). Vitamin E retards the lipid peroxidation resulting from anticancer drug administration. Anticancer Res., 3(1), 59-62.
10. Carlberg, I., and Mannervik, B. (1985). Glutathione Reductase. Methods Enzymol., 113, 484-490.
11. Cozzaglio, L., Doci, R., Colla, G., Zunino, F., Casciarri, G., and Gennari, L. (1990). A feasibility study of high-dose cisplatin and 5-fluorouracil with glutathione protection in the treatment of advanced colorectal cancer. Tumori 76(6), 590-594.
12. Dedon, P. C., and Borch, R. F. (1987). Characterization of the reactions of platinum antitumor agents with biological and non-biological sulfur-containing nucleophiles. Biochem. Pharmacol., 36(12), 1955-1964.
13. DeGregorio, M. W., Gandara, D. R., Holleran, W. M., Perez, E. A., King, C. C., Wold, H. G., Montine, J. T., and Borch, R. F. (1989). High-dose cisplatin with diethyldithiocarbamate (DDTC) rescue therapy: Preliminary pharmacologic observations. Cancer Chemother. Pharmacol., 23(5), 276-278.
14. Di, Re. F., Bohm, S., Oriana, S., Spatti, G. B., and Zunino, F. (1990). Efficacy and safety of high-dose cisplatin and cyclophosphamide with glutathione protection in the treatment of bulky advanced epithelial ovarian cancer. Cancer Chemother. Pharmacol., 25(5), 355-360.
15. Dobyan, D. C., Bull, J. M., Strebel, F. R., Sunderland, B. A., and Bulger, R. E. (1986). Protective effects of O-β-hydroxyethyl-rutoside on cis-platin-induced acute renal failure in the rat. Lab Invest., 55, 557-563.
16. Fariss, M. W., and Reed, D. J. (1987). High-performance liquid chromatography of thiols and disulfides: Dinitrophenol derivatives. Methods Enzymol., 143, 101-109.
17. Flohe, L., and Gunzler, W. (1984). Assays of glutathione peroxidase. Methods Enzymol., 105, 114-121.
18. Fontanelli, R., Spatti, G., Raspagliesi, F., Zunino, F., and Di, Re F. (1992). A preoperative single course of high dose cisplatin and bleomycin with glutathione protection in bulky stage IB/ll carcinoma of the cervix. Ann. Oncol., 3(2), 117-121.
19. Gandara, D. R., Perez, E. A., Weibe, V., and DeGregorio, M. W. (1991). Cisplatin chemoprotection and rescue: Pharmacologic modulation of toxicity. Semin. Oncol., 18(Suppl 3), 49-55.
20. Gandara, D. R., Wiebe, V. J., Perez, E. A., Makuch, R. W., and DeGregorio, M. W. (1990). Cisplatin rescue therapy: Experience with sodium thiosulfate, WR2721, and diethyldithiocarbamate, Crit. Rev. Oncol. Hematol., 10(4), 353-365.
21. Goel, R., Andrews, P. A., Pfeifle, C. E., Abramson, I. S., Kirmani, S., and Howell, S. B. (1990). Comparison of the pharmacokinetics of ultrafil-terable cisplatin species detectable by derivatization with diethyldithiocarbamate or atomic absorption spectroscopy. Eur. J. Cancer 26(1), 21-27.
22. Hannemann, J., and Baumann, K. (1988). Cisplatin-induced lipid peroxidation and decrease of gluconeogenesis in rat kidney cortex: Different effects of antioxidants and radical scavengers. Toxicology 51(2-3), 119131.
23. Howell, S. B., Pfeifle, C. E., Wung, W. E., and Olshen, R. A. (1983). Intraperitoneal cisdiammirtedichloroplatinum with systemic thiosulfate protection. Cancer Res., 43(3), 1426-1431.
24. Howell, S. B., Pfeifle, C. L., Wung, W. E., Olshen, R. A., Lucas, W. E., Yon, J. L., and Green, M. (1982). Intraperitoneal cisplatin with systemic thiosulfate protection. Ann. Intern. Med., 97(6), 845-851.
25. Howell, S. B., and Taetle, R. (1980). Effect of sodium thiosulfate on cis-dichlorodiamminepladnum (II) toxicity and antitumor activity in LI210 leukemia. Cancer Treat. Rep., 64(4-5), 611-616.
26. Ikeda, K., Sunose, H., and Takasaka, T. (1993). Effects of free radicals on the intracellular calcium concentration in the isolated outer hair cell of the guinea pig cochlea. Acta Otolaryngol. (Stockholm) 113, 137-141.
27. Ishikawa, T. (1992). The ATP-dependant glutathione S-conjugate export pump. Trends Biochem. Sci., 17(11), 463-468.
28. Jones, M. M., Basinger, M. A., and Holscher, M. A. (1991). Thioether suppression of cisplatin nephrotoxicity in the rat. Anticancer Res., 11, 449-454.
29. Jones, M. M., Basinger, M. A., and Holscher, M. A. (1992). Control of the nephrotoxicity of cisplatin by clinically used sulphur-containing compounds. Fundam. Appl. Toxicol., 18, 181-188.
30. Laurell, G., Engstriom, B., Hirch, A., Baggre, S. J., and Obiack, D. (1987). Ototoxicity of cisplatin. Int. J. Androl., 10(1), 589-562.
31. Leeuwenkamp, O. R., Van Der Vijgh, W. J., Neijt, J. P., and Pinedo, H. M. (1990). Reaction kinetics of cisplatin and its monoaquated species with the (potential) renal protecting agents (di) mesna and thiosulfate: Estimation of the effect of protecting agents on the plasma and periotoneal AUCs of CDDP. Cancer Chemother. Pharmacol., 27(2), 111-114.
32. McGuiness, J. E., Proctor, P., and Demopoulos, H. (1978). Amelioration of cisplatinum nephrotoxicity by orgotein (superoxide dismutase). Physiol. Chem. Phys., 10, 269-277.
33. Milano, G., Caldani, C., Khater, R., Launay, J. M., Soummer, A. M., Namer, M., and Schneider, M. (1988). Time- and dose-dependent inhibition of erythrocyte glutathione peroxidase by cisplatin. Biochem. Pharmacol., 37(5), 981-982.
34. Misra, H. P., and Fridovich, I. (1972). The role of superoxide anion in the autooxidation of the epinephrine and a sample assay for superoxide dismutase. J. Biol. Chem., 247, 3170-3175.
35. Montine, T. J., and Borch, R. F. (1990). Role of endogenous sulfur-containing nucleophiles in an in vitro model of cis-diamminedichloroplad-num (II)-induced nephrotoxicity. Biochem. Pharmacol., 39(11), 1751-1757.
36. Naganuma, A., Anderson, M. E., and Meister, A. (1990). Cellular glutathione is a determinant of sensitivity to mercuric chloride toxicity; prevention of toxicity by giving glutathione monoester. Biochem. Pharmacol., 40, 693-697.
37. Nakano, S., and Gemba, M. (1989). Potentiation of cisplatin-induced lipid peroxidation in kidney cortical sliced by glutathione depletion. Jpn. J. Pharmacol., 50(2), 87-92.
38. Otto, N. C., Brown, R. D., Gage-White, L., Kupetz, S., Anniko, M., Penny, J. E., and Henley, C. M. (1988). Effects of cisplatin and thiosulphate upon auditory brain stem responses of guinea pig. Hear. Res., 35(1), 79-85.
39. Qazi, R., Chang, A. Y., Borch, R. F., Montine, T., Dedon, P., Loughner, J., and Bennett, J. M. (1988). Phase I clinical and pharmacokinetic study of diethyldithiocarbamate as a chemoprotector from toxic effects of cisplatin. J. Natl. Cancer Inst., 80(18), 1486-1488. [Published erratum appears in J. NatL Cancer Inst. (1989) 81(6), 46]
40. Quick, C. A., Fish, A., and Brown, C. (1983) Relationship between cochlea and kidney. Laryngoscope 73, 1469-1481.
41. Ravi, R., Rybak, L. P., Hoffman, D., Whitworth, C., and Scott, V. (1992) Diethyldithiocarbamate protects against cisplatin ototoxicity and nephrotoxicity. Otolaryngol. Head Neck Surg., 107(2), 232.
42. Ravi, R., Rybak, L. P., and Somani, S. M. (1991). Relationship of pharmacodynamic effects of cisplatin to the glutathione levels in the cochlea, inferior colliculus, and kidney. Pharmacologist 33(3), 402.
43. Rybak, L. P. (1993) Ototoxicity of loop diuretics. In Otolaryngology Clinics of North America., (L. P. Rybak, Ed.), Vol. 26, pp. 829-844. Saunders, Philadelphia.
44. Rybak, L. P., and Matz, G. J. (1993). Effects of toxic agents. In Otolaryngology and Head and Neck Surgery., (C. W. Cummings et al., Eds.), 2nd ed., Vol. 4, pp. 2943-2964. Mosby, SL Louis.
45. Rybak, L. P., Ravi, R., and Somani, S. M. (1992). Pharmacodynamics and biochemical basis for protection of cisplatin oto- and nephroprotection by DDTC. Pharmacologist 34(3), 409.
46. Schweitzer, V. G., Dolan, D. F., Abrams, G. E., Davidson, T., and Snyder, R. (1986). Ameliorations of cisplatin-induced ototoxicity by fosfomycin. Laryngoscope 96(9, part 1), 948-958.
47. Singhal, R. K., Anderson, M. E., and Meister, A. (1987). Glutathione, a first line of defense against cadmium toxicity. FASEB J., 1, 220-223.
48. Smith, V. C., and Mitchell, J. R. (1989). Pharmacological Aspects of Glutathione in Drug Metabolism. Glutathione: Chemical, Biochemical, and Medical Aspects., (D. Dolphin, O. Avramovibc, and R. Poulson, Eds.) Wiley, New York.
49. Somani, S. M., Ravi, R., and Rybak, L. P. (1994). Diethyldithiocarbamate protection against cisplatin nephrotoxicity: Antioxidant system. Drug Chem. Toxicol., in press.
50. Stadnicki, S. W., Gleischman, R. W., and Schaeppi, U. (1975). Ototoxicity of cis-dichlorodiammine platinum (II) (NSC-119875): Hearing loss and other toxic effects in Rhesus monkeys. Cancer Chemother. Rev., 59, 467480.
51. Sugihara, K., Nakano, S., and Gemba, M. (1987a). Effect of cisplatin on in vitro production of lipid peroxides in rat kidney cortex. Jpn. J. Pharmacol., 44(1), 71-76.
52. Sugihara, K., Nakano, S., Koda, M., Tanaka, K., Fukuishi, N., and Gemba, M. (1987b). Stimulatory effect of cisplatin on production of lipid peroxidation in renal tissues. Jpn. J. Pharmacol 43(3), 247-252.
53. Sugiyama, S., Hayakawa, M., Kato, T., Hanki, Y., Shimizu, K., and Ozawa, T. (1989). Adverse effects of anti-tumor drug, cisplatin, on rat kidney mitochondria: Disturbances in glutathione peroxidase activity. Biochem. Biophys. Res. Common., 159(3), 1121-1127.
54. Tedeschi, M., Bohm, S., Di, Re. F., Oriana, S., Spatti, G. B., Tognella, S., and Zunino, F. (1991). Glutathione and detoxification. Cancer Treat. Rev., 17(2-3), 203-208.
55. Tognella, S. (1990). Pharmacological interventions to reduce platinum-induced toxicity. Cancer Treat. Rev., 17(2-3), 139-142.
56. Trotta, R. J., Sullivan, S. G., and Sem, S. D. (1982). Lipid peroxidation and hemoglobin degradation in red blood cells exposed to r-butyl hydroperoxide. Effects of the hexose monophosphate shunt as mediated by glutathione and ascorbate. Biochem. J., 204(2), 405-415.
57. Yuhas, J. M., and Culo, F. (1980). Selective inhibition of the nephrotoxicity of cis-dichlorodiammineplatinum (II) by WR2721 without altering its antitumor properties. Cancer Treat. Rep., 64(1), 57-64.
58. Zhang, J. G., Zhong, L. F., Zhang, M., and Xia, Y. X. (1992). Protection effects of procaine on oxidative stress and toxicides of renal cortical slices from rats caused by cisplatin in in vitro. Arch. Toxicol., 66(5), 354-358.
59. Zunino, F., Pratesi, G., Micheloni, A., Cavalletti, E., Sala, F., and Tofanet, O. (1989). Protective effect of reduced glutathione against cisplatin-induced renal and systemic toxicity and its influence on the therapeudc acuvity of the and tumor drug. Chem. Biol. Interact., 70(1-2), 89-101.
60. Zunino, F., Tofanetti, O., Besad, A., Cavalletd, E., and Savi, G. (1983). Protecdve effect of reduced glutathione against cis-dichlorodiammine platinum (II)-induced nephrotoxicity and lethal toxicity. Tumori 69(2), 105-111.